IL13RA2 and central nervous system cancer: In one approach, Principal Component Analysis (PCA) was used to evaluate potential associations of IL13Rα2 with expression of signature genes identified by Verhaak et al. [5] and Phillips et al. [6] to distinguish between subclasses of high-grade gliomas.